Buriticá Site Visit Confirms Highly Attractive Project
We were on site this week at CNL's Buriticá project in Columbia. Overall, we come away from the visit encouraged by the positive trial mining results to date and the approach of the team on the ground in Columbia.
Next Steps Post-Permitting
With all environmental permits now in hand, management is now focused on detailed engineering of the Buriticá project....
Our underground tour allowed us to visit underground test stopes and cross cuts in the San Antonio (Yaragua) and Murciealagos (Yaragua) vein packages. Results from significantly wider and higher grade results that suggest potential for upside to feasibility study assumptions...
Our meeting with local community leaders highlighted the strong support for the project and company in Buriticá and the quality of its CSR program locally...
Clarus is an idea shop. We don’t cover all sectors and we don’t cover all the names in a space. By being very select in a sector, we try to deliver the best ideas that generate the best absolute returns to investors. We have been helping our clients with ideas like these lately:
We got involved in the medical marijuana space early, some 2 ½ years ago, and have delivered extraordinary returns to investors by way of names like Aphria (APH), our first idea in the space in July 2014 had an equity value of $41 million (share price $0.78/sh) and is now $750 million (recent price $6.70/sh). We have been publicly involved with multiple cannabis related companies and have become a go-to player in the emergent space.
Our mining group has been outstanding at generating ideas like: Endeavour Mining, a deep value turnaround story, whose market cap when we initiated in February 2015 was $223 million ($5.40/sh) at writing was $2,374 million ($25.39/sh) ; Golden Predator (GPY), a new exploration play in Canada’s Yukon that is proving up a potentially major new play and Cardinal Resources (CDV-ASX) which is delineating the large Namdini play in Ghana.
In special situations we identified: CRH Medical, a gastrointestinal company in early 2015, trading at $3.62/sh ($250 million) it recently surpassed $11.00/sh (equity value $800 million); Polaris Infrastructure, a geothermal energy turnaround and growth story, in January 2016 traded at $8.05/sh ($125 million) and recently traded at $14.30/sh ($225 million) having traded as high as $18.80/sh.
Our focus on oil and gas explorers like Leucrotta Exploration whose recovery from $0.83/sh (EV $98 million) to a recent $2.40/sh ($354 million) or Yangarra Resources trading from $0.48/sh ($85 million) in January 2016 to a recent $2.64/sh ($276 million), have strongly outperformed the sector because they are not commodity price calls but fundamental reserve growth stories.
Markets Were Open in Q1 2017
As markets opened up in Q1 2017, Clarus nimbly participated with a very active calendar. We participated in 15 transactions raising a total of $273 million. The cannabis space remained active with four transactions, the mining exploration space heated up with five deals and the healthcare, technology and special sits area saw six transactions.
Clarus was active in Q4/16 as it was involved in seven transactions raising a total of $444 million. We maintained our marquee position in the emerging marijuana space having participated in four transactions (two as lead) raising a total of $105 million. Other major transactions were completed raising $288 million in the oil and gas sector, and $51 million in the technology and diversified spaces.